HILPDA
HILPDA (hypoxia inducible lipid droplet associated, also known as HIG-2, HIG2, FLJ21076 and C7orf68) is a small protein that increases intracellular lipid accumulation. It is induced in the cellular response to hypoxia and has been linked to cell growth and cytokine expression. Browse Assay Genie's current range of HILPDA research reagents below, or read on for the biology behind the target.
HILPDA increases intracellular lipid accumulation and is involved in the positive regulation of lipid storage. It also stimulates the expression of cytokines, including IL-6, MIF and VEGFA, and enhances cell growth and proliferation. Annotation from NCBI Gene places it among the genes involved in the cellular response to hypoxia and in autocrine signalling, and records signalling receptor binding activity.
The HILPDA protein is found in several cellular compartments. UniProt lists lipid droplet, secreted and membrane locations, and NCBI Gene describes it in lipid droplets and secretory granules as well as the extracellular space. This spread of locations is consistent with a role both within the cell, in lipid handling, and in signalling between cells. The mouse ortholog is named Hilpda.
The gene has had several names. Earlier symbols and aliases include C7orf68, HIG-2, HIG2 and FLJ21076, and previous names were chromosome 7 open reading frame 68 and hypoxia inducible lipid droplet-associated. In disease research, HILPDA is implicated in colorectal cancer and hepatocellular carcinoma, and it is described as a biomarker of both. Researchers studying hypoxia signalling, lipid metabolism or tumour biology may use a HILPDA antibody or HILPDA ELISA kit to examine its expression and localisation.
HILPDA is involved in the cellular response to hypoxia, making it a useful readout in studies of how cells adapt to low oxygen.
HILPDA localises to lipid droplets and positively regulates lipid storage, so it is relevant to studies of intracellular lipid accumulation.
HILPDA is implicated in colorectal cancer and hepatocellular carcinoma and is described as a biomarker of both.
HILPDA stimulates expression of IL-6, MIF and VEGFA and enhances cell growth and proliferation, linking it to autocrine signalling studies.
HILPDA increases intracellular lipid accumulation and positively regulates lipid storage. It also stimulates expression of cytokines including IL-6, MIF and VEGFA and enhances cell growth and proliferation. It is involved in the cellular response to hypoxia and in autocrine signalling.
HILPDA is also known as HIG-2, HIG2, FLJ21076 and C7orf68. Its previous names were chromosome 7 open reading frame 68 and hypoxia inducible lipid droplet-associated. These names may all appear in older literature and database records.
NCBI Gene reports that HILPDA is implicated in colorectal cancer and hepatocellular carcinoma, and describes it as a biomarker of both. A mouse ortholog, Hilpda, exists; check the datasheet of any product for its validated reactivity.
Cytokines and growth factors whose expression HILPDA stimulates, plus hypoxia-pathway markers.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9Y5L2; product specifications from Assay Genie datasheets.